Jiren Zhang
- Molecular Biology
- Cancer Research top 10%
- Oncology
- Pulmonary and Respiratory Medicine
- Public Health, Environmental and Occupational Health
- Topics
- Epigenetics and DNA Methylation (6 papers)RNA modifications and cancer (6 papers)Cancer-related gene regulation (5 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jiren Zhang
52 papers receiving 815 citations
Peers
Comparison fields: 5 of 113
- Molecular Biology 431
- Cancer Research 177
- Oncology 121
- Pulmonary and Respiratory Medicine 80
- Public Health, Environmental and Occupational Health 76
Countries citing papers authored by Jiren Zhang
This map shows the geographic impact of Jiren Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiren Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiren Zhang more than expected).
Fields of papers citing papers by Jiren Zhang
This network shows the impact of papers produced by Jiren Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiren Zhang. The network helps show where Jiren Zhang may publish in the future.
Co-authorship network of co-authors of Jiren Zhang
This figure shows the co-authorship network connecting the top 25 collaborators of Jiren Zhang. A scholar is included among the top collaborators of Jiren Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiren Zhang. Jiren Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 26 | |
| 2 | 17 | |
| 3 | 25 | |
| 4 | Luteolin enhances the antitumor activity of lapatinib in human breast cancer cells | 8 |
| 5 | 13 | |
| 6 | 20 | |
| 7 | 10 | |
| 8 | 7 | |
| 9 | 43 | |
| 10 | 45 | |
| 11 | Bioinformatics Analysis of the Key Risk Genes in Lung Cancer | 1 |
| 12 | Screening peptide mimotopes of blood group B carbohydrate antigen using phage display peptide library | 1 |
| 13 | Comparison of the grade of concordance in terms of K-ras status between primaries and related liver metastases in colorectal cancer | 2 |
| 14 | [Therapeutic effect of para-toluenesulfonamide on transplanted hepatocarcinoma in nude mice]. | 3 |
| 15 | Effects of NADH on DENA-induced H-ras gene mutation and expression of c-erbB-2 gene in L02 cells. | 1 |
| 16 | 6 | |
| 17 | [Dose-effect relationship of para-toluenesulfonamide for treatment of hepatocellular carcinoma in rats]. | 4 |
| 18 | 30 | |
| 19 | [In vitro regulation of HLA and B7 expression in multidrug-resistant breast cancer cells]. | 2 |
| 20 | 26 |
About Jiren Zhang
Jiren Zhang is a scholar working on Cancer Research, Aging and Hepatology, having authored 54 papers that have together received 830 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), RNA modifications and cancer (6 papers) and Cancer-related gene regulation (5 papers). The work is most often cited by research in Cancer Research (177 citations), Molecular Biology (431 citations) and Oncology (121 citations). Jiren Zhang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yanfang Zheng, Xufeng Li, Rong Zeng, Junpeng Huang, Rui Cai, Jcm Ho, Zhiguo Rao, Murray P. Deutscher, Matthew D. Schroeder and Stefan Groß. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.